Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcivit is a mineral and vitamin supplement developed by GyneBio Pharma, primarily indicated for the treatment and prevention of calcium and vitamin D deficiencies, as well as an adjunct in osteoporosis management. The formulation combines calcium (typically as calcium carbonate), vitamin D3 (cholecalciferol), and magnesium. Calcium is essential for maintaining bone mass and structural integrity. Vitamin D3 facilitates the intestinal absorption of calcium and regulates bone mineralization by acting on the vitamin D receptor (VDR). Magnesium acts as a cofactor in bone-related enzymatic processes and is necessary for the conversion of vitamin D into its active form, providing a comprehensive approach to bone health and mineral homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium + cholecalciferol + magnesium.